Infographics_Connected_Smart_Drug_Delivery_Systems_Market.jpg

Connected Smart Drug Delivery Systems Market Size, Share & Trends Analysis Report By Product, By Therapeutic Area (Metabolic Disorders, Neurological Disorders, Respiratory Disorders, Others), By End-User, By Region, And Segment Forecasts, 2025-2034

Report Id: 1291 Pages: 180 Published: 04 March 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

The Connected Smart Drug Delivery Systems Market Size is valued at USD 4.2 Billion in 2024 and is predicted to reach USD 10.5 Billion by the year 2034 at a 10.0% CAGR during the forecast period for 2025-2034. 

 connected smart drug delivery devices market INFO

Connected Smart Drug Delivery Systems are the devices which perform multiple functions with the highest degree of smartness. Smart drug delivery devices help to reduce the dosage, frequency of the dosage and adverse effects of the drug. These devices are beneficial in the treatment of respiratory diseases, diabetes and other cardiovascular disorders. Connected smart drug delivery systems are more effective and can be self-managed. COVID-19 Pandemic is significantly augmenting the need for such smart (contactless) devices, and hence, in future, there will be a high requirement for such systems, which will ultimately result in Connected Smart Drug Delivery System’s market growth.

Connected smart drug delivery is an attractive industry option with multiple growth opportunities in research and development, technologies, applications, and formulations. Market analysis in terms of the product clearly suggests that the connected sensors segment dominated the market. And the COVID-19 Pandemic is also fueling new developments in the respiratory sector (inhalation devices). Also, recently a Rutgers-led team has created a smart drug delivery system that reduces inflammation in damaged nervous tissues and may help treat spinal cord injuries and other neurological disorders.

Spreading awareness regarding the benefits of connected smart systems over conventional systems is expected to enhance the product demand. Fast adoption of new technologies and smart devices, the invention of new products according to patients’ requirements, and the creation of smartphone applications and low-cost connectivity devices will also help grow this market.

Market Segmentation 

The global connected smart drug delivery systems market is segmented on the basis of products, therapeutic area, end user and region. Products market is further categorized into connected inhalers, connected auto injectors, connected needle-free injectors, connected pen injectors, connected insulin pumps, connected wearable injectors/patch pumps, add-on sensors. Based on the different disorders market of therapeutic area can be subdivided into metabolic disorders, neurological disorders, respiratory disorders and others. On the basis of end user, market is sub-divided into hospitals, clinics, and homecare.  Based on the region, the market of connected smart drug delivery systems has been segmented into north America, Asia-Pacific, Europe, And LAMEA. Among all, North America is expected to dominate the market during the analysis of forecast period. 

Competitive Landscape

Some Of The Key Players In The Connected Smart Drug Delivery Systems Market:

  • BIOCORP,
  • Elcam Drug Delivery Devices (E3D),
  • Novo Nordisk,
  • Merck,
  • Pneuma Respiratory,
  • H&T Presspart,
  • Nemera,
  • Ypsomed Holdings,
  • Unolife Corporation,
  • Quio Technologies,
  • SHL Group,
  • Haselmeier Inc.,
  • Portal Instruments Inc,
  • West Pharmaceutical Services Inc. ,
  • Emperra GmbH E-Health Technologies,
  • Amiko Digital Health Limited,
  • Cognita Labs,
  • DIAMESCO CO., Ltd.,
  • Eitan Medical (Q Core Medical Ltd.,
  • Avoset Health, Sorrel Medical),
  • Enable Injections,
  • Bigfoot Biomedical Inc.,
  • Medtronic Plc,
  • Companion Medical ,
  • Sorrel Medical,
  • Cohero Health, Inc.,
  • Propeller Health,
  • Pendiq Intelligent Diabetes Care,
  • Phillips-Medisize,
  • Becton, Dickinson and Company (BD),
  • Noble International Inc,
  • etectRx,
  • Aterica Inc.,
  • Findair Sp. z o. o.,
  • Recipharm AB,
  • Aero Pump GmbH,
  • Jiangsu Delfu medical device Co.,Ltd,
  • other prominent players.

The Connected Smart Drug Delivery Systems Market Report Scope

Report Attribute

Specifications

Market Size Value In 2024

USD 4.2 Billion

Revenue Forecast In 2034

USD 10.5 Billion

Growth Rate CAGR

CAGR of 10.0% from 2025 to 2034

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2024 to 2031

Historic Year

2021 to 2024

Forecast Year

2025-2034

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product, By Therapeutic Area, By End-User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ; France; Italy; Spain; Japan; South Korea; South East Asia

Competitive Landscape

BIOCORP, Elcam Drug Delivery Devices (E3D), Novo Nordisk, Merck, Pneuma Respiratory, H&T Presspart, Nemera, Ypsomed Holdings, Unolife Corporation, Quio Technologies, SHL Group, Haselmeier Inc., Portal Instruments Inc, West Pharmaceutical Services Inc. , Emperra GmbH E-Health Technologies, Amiko Digital Health Limited, Cognita Labs,DIAMESCO CO., Ltd., Eitan Medical (Q Core Medical Ltd., Avoset Health, Sorrel Medical) , Enable Injections, Bigfoot Biomedical Inc., Medtronic Plc, Companion Medical , Sorrel Medical, Cohero Health, Inc., Propeller Health, Pendiq Intelligent Diabetes Care, Phillips-Medisize, Becton, Dickinson and Company (BD), Noble International Inc, etectRx, Aterica Inc., Findair Sp. z o. o., Recipharm AB, Aero Pump GmbH, Jiangsu Delfu medical device Co.,Ltd, and other prominent players.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 


Deprecated: stripslashes(): Passing null to parameter #1 ($string) of type string is deprecated in /home/z8nbkwptb7pj/public_html/report-details.php on line 209

Market Segmentation Of Connected Smart Drug Delivery Systems Market

Market Size (Value & Volume) & Forecasts and Trend Analyses, by Products

  • Connected Inhalers
  • Connected Auto injectors
  • Connected Needle-Free Injectors
  • Connected Pen injectors
  • Connected Insulin Pumps
  • Connected Wearable Injectors/Patch Pumps
  • Add-On Sensors

connected smart drug

Market Size (Value & Volume) & Forecasts and Trend Analyses, by Therapeutic Area

  • Metabolic Disorders
  • Neurological Disorders
  • Respiratory Disorders
  • Others

Market Size (Value & Volume) & Forecasts and Trend Analyses, by based on End-User

  • Hospitals
  • Clinics
  • Homecare 

Market Size (Value & Volume) & Forecasts and Trend Analyses, by based on region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Europe Connected Smart Drug Delivery Systems Market Revenue by Country, 

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America Connected Smart Drug Delivery Systems Market Revenue by Country, 

  • U.S.
  • Canada

Asia Pacific Connected Smart Drug Delivery Systems Market Revenue by Country, 

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Connected Smart Drug Delivery Systems Market Revenue by Country, 

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Connected Smart Drug Delivery Systems Market Revenue by Country, 

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development

Latest Strategic Developments

Companies Mentioned

  • BIOCORP
  • Elcam Drug Delivery Devices (E3D)
  • Novo Nordisk
  • Merck
  • Pneuma Respiratory
  • H&T Presspart
  • Nemera
  • Ypsomed Holdings
  • Unolife Corporation
  • Quio Technologies
  • SHL Group
  • Haselmeier Inc.
  • Portal Instruments Inc
  • West Pharmaceutical Services Inc.
  • Emperra GmbH E-Health Technologies
  • Amiko Digital Health Limited
  • Cognita Labs
  • DIAMESCO CO., Ltd.?
  • Eitan Medical 
  • Enable Injections
  • Bigfoot Biomedical Inc.
  • Medtronic Plc
  • Companion Medical
  • Cohero Health, Inc.
  • Propeller Health
  • Pendiq Intelligent Diabetes Care
  • Phillips-Medisize
  • Becton, Dickinson and Company (BD)
  • Noble International Inc
  • etectRx
  • Aterica Inc.
  • Findair Sp. z o. o.
  • Recipharm AB
  • Aero Pump GmbH
  • Jiangsu Delfu medical device Co.,Ltd
  • List of Other Prominent Players

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.
Frequently Asked Questions

Medical Stick-to-Skin Adhesives Market Size is valued at USD 2.48 Bn in 2024 and is predicted to reach USD 5.18 Bn by the year 2034

Medical Stick-to-Skin Adhesives Market is expected to grow at a 7.8% CAGR during the forecast period for 2025-2034.

DermaMed Coatings Company, LLC (US), Paul Hartmann AG (Germany), Mactac (US), Sekisui Kasei Co., Ltd. (Japan), Shurtape Technologies, LLC (US) and Adh

medical stick-to-skin adhesives market is segmented based on product, material type, backing material, application, and end user.

North America region is leading the medical stick-to-skin adhesives market.

Releated Report Box